PHC Holdings Corp
TSE:6523
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
PHC Holdings Corp
Operating Income
PHC Holdings Corp
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
PHC Holdings Corp
TSE:6523
|
Operating Income
¥22.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Terumo Corp
TSE:4543
|
Operating Income
¥169B
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Olympus Corp
TSE:7733
|
Operating Income
¥153.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
4%
|
|
|
Sysmex Corp
TSE:6869
|
Operating Income
¥68.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
JEOL Ltd
TSE:6951
|
Operating Income
¥30.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
35%
|
CAGR 10-Years
16%
|
|
|
Fukuda Denshi Co Ltd
TSE:6960
|
Operating Income
¥24.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
PHC Holdings Corp
Glance View
PHC Holdings Corp. engages in the development, manufacture, and sale of healthcare devices and services. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 9,374 full-time employees. The company went IPO on 2021-10-14. The firm operates through three business segments. The Diabetes Management segment is involved in the development, manufacture and sale of in vitro diagnostic equipment such as self-monitoring blood glucose systems and point-of-care testing (POCT) products and electric drug injectors. The Healthcare Solutions segment is involved in the development and sale of medical information technology (IT) products such as receipt computers and electronic medical records, as well as the development of clinical laboratory diagnosis business. The Diagnostic and Life Science segment is involved in the development, manufacture and sale of research and medical support equipment, pathological diagnosis equipment, among others.
See Also
What is PHC Holdings Corp's Operating Income?
Operating Income
22.4B
JPY
Based on the financial report for Mar 31, 2025, PHC Holdings Corp's Operating Income amounts to 22.4B JPY.
What is PHC Holdings Corp's Operating Income growth rate?
Operating Income CAGR 5Y
8%
Over the last year, the Operating Income growth was 60%. The average annual Operating Income growth rates for PHC Holdings Corp have been -5% over the past three years , 8% over the past five years .
